SEC-sourced researchBeta
RARE
Ultragenyx Pharmaceutical Inc.
Company comparison ↗
Data passport
- CIK
- 0001515673
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Nov 13, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 434,000,000.0000 | Feb 18, 2026 |
| December 2024 | 560,000,000.0000 | Feb 18, 2026 |
| December 2025 | 673,000,000.0000 | Feb 18, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 673,000,000.0000 | -575,000,000.0000 | -466,000,000.0000 | 1,532,000,000.0000 | 1,605,000,000.0000 | Feb 18, 2026 |
| December 2024 | 560,000,000.0000 | -569,000,000.0000 | -414,000,000.0000 | 1,503,000,000.0000 | 1,241,000,000.0000 | Feb 18, 2026 |
| December 2023 | 434,000,000.0000 | -607,000,000.0000 | -475,000,000.0000 | — | — | Feb 18, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $673M | December 2025 | Feb 18, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $560M | December 2024 | Feb 18, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$575M | December 2025 | Feb 18, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$466M | December 2025 | Feb 18, 2026 | 10-K |
| Total assetsAssets | $1.53B | December 2025 | Feb 18, 2026 | 10-K |
| Total liabilitiesLiabilities | $1.61B | December 2025 | Feb 18, 2026 | 10-K |
New filings
- SCHEDULE 13G/ARARE · Ultragenyx Pharmaceutical Inc.Nov 13, 2026 · Other
- SCHEDULE 13GRARE · Ultragenyx Pharmaceutical Inc.Nov 10, 2026 · Other
- 10-QRARE · Ultragenyx Pharmaceutical Inc.Nov 4, 2026 · Periodic
- 8-KRARE · Ultragenyx Pharmaceutical Inc.Nov 3, 2026 · Current event
- SCHEDULE 13G/ARARE · Ultragenyx Pharmaceutical Inc.Oct 30, 2026 · Other
- SCHEDULE 13GRARE · Ultragenyx Pharmaceutical Inc.Oct 20, 2026 · Other
- 4RARE · Ultragenyx Pharmaceutical Inc.Oct 19, 2026 · Other
- 8-KRARE · Ultragenyx Pharmaceutical Inc.Oct 19, 2026 · Current event
- 8-KRARE · Ultragenyx Pharmaceutical Inc.Oct 14, 2026 · Current event
- 8-KRARE · Ultragenyx Pharmaceutical Inc.Oct 7, 2026 · Current event